Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis
“Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis”, vol. 14, pp. 17068-17078, 2015.
, Cumulated evidence indicates that matrix metalloproteinase-3 (MMP-3) is significantly involved in cancer progression. Recent studies yielded conflicting results regarding the association between serum MMP-3 and ankylosing spondylitis (AS). To clarify this correlation, we performed a meta-analysis. Potential relevant studies were identified by searching the following databases: PubMed, Embase, CINAHL, Science Citation Index database, the Cochrane Library, Current Contents Index, Chinese Biomedical, the Chinese Journal Full-Text, and the Weipu Journal.